Notizie
Più notizie
-
-
-
15.06.2022
Investment Outlook 2022 – mid-year update
The investment landscape has changed substantially in the last six months: conflict has broken out in Ukraine, leading to various geopolitical and social ramifications, and inflationary pressure has been rising and remains a concern across many regions.
-
24.05.2022
“I am not holding my breath for a soft landing”
Finews (19.05.2022) - Financial markets are not about to return to the normality of past years, says Norman Villamin, CIO Wealth Management, to finews.ch.
-
26.04.2022
“The main aim is to avoid any accidents related to rising interest rates”
Le Temps (20.04.2022) - The war in Ukraine has created a highly unusual environment for investors, writes Michaël Lok, Group Chief Investment Officer at UBP.
-
19.01.2022
«The Fed will be selling bonds faster than 2017»
Finanz und Wirtschaft (17.01.2022) - Norman Villamin, CIO Wealth Management of Union Bancaire Privée, expects a radical shift in monetary policy. A tightening cycle is less bad for equities than for bonds and gold, he says.
-
22.11.2021
CRISPR: the implications of gene editing
In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.
-
-
11.06.2021
Transitioning to a Brave New World
Volatility is back in Chinese equity markets: after rallying 90% from its trough in March 2020 to a peak in February 2021, MSCI China has fallen by 16% over the past month.
-
12.05.2021
No sharp rate rises on the Fed’s watch
Finanz und Wirtschaft (19.01.2021) - Norman Villamin, Chief Investment Officer Wealth Management of Union Bancaire Privée, considers fears of significantly higher interest rates to be premature. He prefers mining to banking stocks.
-
06.05.2021
Why the Japanese market is performing well again
Japan’s equity markets have outpaced other major developed market equities in both 2020 and year-to-date in 2021 as the world seeks to transition to a post-pandemic recovery.
-
14.04.2021
The vaccine disrupting the pharma industry
UBP talks to Stéphane Bancel, Moderna CEO, to learn how the mRNA technology not only made one of the first COVID-19 vaccines possible, but, more importantly for investors, has the potential to disrupt the broader pharmaceutical industry in its wake.
Our latest podcasts
-
Europe: rewriting its future
Relatori: Norman Villamin, Patrice Gautry, Peter Kinsella
-
DeepSeek: Chinese challenger enters the AI race
Relatori: Dimitri Kallianiotis
Our latest podcasts
-
From peak to peak with patience and passion
-
Finnish ex-premier addresses UBP clients
Relatori: Adrian Künzi